Skip to main content
Top
Published in: International Journal of Hematology 5/2008

01-12-2008 | Letter to the Editor

Human leukocyte antigen-DR negative de novo acute myeloid leukemia with Philadelphia chromosome

Authors: Tohru Inaba, Hiroshi Nishimura, Junko Saito, Yoko Yamane, Takuya Nakatani, Mio Yamamoto, Hitoji Uchiyama, Naohisa Fujita

Published in: International Journal of Hematology | Issue 5/2008

Login to get access

Excerpt

It is well known that human leukocyte antigen (HLA)-DR is present in the majority of acute myeloid leukemia (AML) [1, 2]. However, acute promyelocytic leukemia (APL) with t(15;17)(q22;q12) usually lacks the HLA-DR expression as well as CD34 expression [2, 3]. Recently, such HLA-DR/CD34 phenotype has also been described in a subset of AML with cuplike nuclear invaginations (AML-cuplike) [4]. Cytogenetically or molecular genetically, AML-cuplike is characterized with normal karyotype and high frequency of FMS-like tyrosine kinase 3 (FLT3) gene internal tandem duplication (ITD) as well as nucleophosmin (NPM1) gene mutation [4, 5]. In this paper, we reported an extremely rare case of HLA-DR/CD34 AML, which was not categorized into either APL or AML-cuplike and showed Philadelphia chromosome (Ph) at diagnosis. …
Literature
3.
go back to reference Jaffe ES, Harris NL, Stein H, Vardiman JW. WHO classification of tumors: pathology and cytogenetics of tumours of the haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001. Jaffe ES, Harris NL, Stein H, Vardiman JW. WHO classification of tumors: pathology and cytogenetics of tumours of the haematopoietic and lymphoid tissues. Lyon: IARC Press; 2001.
4.
go back to reference Kussick SJ, Stirewalt DL, Yi HS, Sheets KM, Pogosova-Agadjanyan E, Braswell S, et al. A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication. Leukemia. 2004;18:1591–8. doi:10.1038/sj.leu.2403458.CrossRefPubMed Kussick SJ, Stirewalt DL, Yi HS, Sheets KM, Pogosova-Agadjanyan E, Braswell S, et al. A distinctive nuclear morphology in acute myeloid leukemia is strongly associated with loss of HLA-DR expression and FLT3 internal tandem duplication. Leukemia. 2004;18:1591–8. doi:10.​1038/​sj.​leu.​2403458.CrossRefPubMed
5.
go back to reference Chen W, Rassidakis GZ, Li J, Routbort M, Jones D, Kantarjian H, et al. High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations (“cuplike” nuclei). Blood. 2006;108:1783–4. doi:10.1182/blood-2006-03-014340.CrossRefPubMed Chen W, Rassidakis GZ, Li J, Routbort M, Jones D, Kantarjian H, et al. High frequency of NPM1 gene mutations in acute myeloid leukemia with prominent nuclear invaginations (“cuplike” nuclei). Blood. 2006;108:1783–4. doi:10.​1182/​blood-2006-03-014340.CrossRefPubMed
7.
go back to reference Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, et al. HLA-DR−, CD33+, CD56+, CD16− myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French–American–British acute myeloid leukemia-M3. Blood. 1994;84:244–55.PubMed Scott AA, Head DR, Kopecky KJ, Appelbaum FR, Theil KS, Grever MR, et al. HLA-DR, CD33+, CD56+, CD16 myeloid/natural killer cell acute leukemia: a previously unrecognized form of acute leukemia potentially misdiagnosed as French–American–British acute myeloid leukemia-M3. Blood. 1994;84:244–55.PubMed
8.
go back to reference Paietta E, Racevskis J, Bennett JM, Neuberg D, Cassileth PA, Rowe JM, et al. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia. 1998;12:1881–5. doi:10.1038/sj.leu.2401229.CrossRefPubMed Paietta E, Racevskis J, Bennett JM, Neuberg D, Cassileth PA, Rowe JM, et al. Biologic heterogeneity in Philadelphia chromosome-positive acute leukemia with myeloid morphology: the Eastern Cooperative Oncology Group experience. Leukemia. 1998;12:1881–5. doi:10.​1038/​sj.​leu.​2401229.CrossRefPubMed
10.
go back to reference Soupir CP, Vergilio J, Cin PD, Muzikansky A, Kantarjian H, Jones D, et al. Philadelphia chromosome-positive acute myeloid leukemia. A rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol. 2007;127:642–50. doi:10.1309/B4NVER1AJJ84CTUU.CrossRefPubMed Soupir CP, Vergilio J, Cin PD, Muzikansky A, Kantarjian H, Jones D, et al. Philadelphia chromosome-positive acute myeloid leukemia. A rare aggressive leukemia with clinicopathologic features distinct from chronic myeloid leukemia in myeloid blast crisis. Am J Clin Pathol. 2007;127:642–50. doi:10.​1309/​B4NVER1AJJ84CTUU​.CrossRefPubMed
Metadata
Title
Human leukocyte antigen-DR negative de novo acute myeloid leukemia with Philadelphia chromosome
Authors
Tohru Inaba
Hiroshi Nishimura
Junko Saito
Yoko Yamane
Takuya Nakatani
Mio Yamamoto
Hitoji Uchiyama
Naohisa Fujita
Publication date
01-12-2008
Publisher
Springer Japan
Published in
International Journal of Hematology / Issue 5/2008
Print ISSN: 0925-5710
Electronic ISSN: 1865-3774
DOI
https://doi.org/10.1007/s12185-008-0204-2

Other articles of this Issue 5/2008

International Journal of Hematology 5/2008 Go to the issue
Webinar | 19-02-2024 | 17:30 (CET)

Keynote webinar | Spotlight on antibody–drug conjugates in cancer

Antibody–drug conjugates (ADCs) are novel agents that have shown promise across multiple tumor types. Explore the current landscape of ADCs in breast and lung cancer with our experts, and gain insights into the mechanism of action, key clinical trials data, existing challenges, and future directions.

Dr. Véronique Diéras
Prof. Fabrice Barlesi
Developed by: Springer Medicine